Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, RPG Life Sciences has informed that a meeting of the Board of Directors of the Company is scheduled on Monday, November 5, 2018, to consider and approve the Unaudited Financial Results for the quarter and half year ended September 30, 2018.Further, pursuant to the Code of Fair Disclosures & Conduct of the Company for regulating, monitoring and reporting of trading by insiders, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in Securities by Promoters, Directors, Key Managerial Persons and Designated Persons, shall remain closed from Tuesday, October 30, 2018 to Wednesday, November 7, 2018.
The above information is a part of company’s filings submitted to BSE.
